Bromfenac Sodium and Insulin Glargine (U-300) Pens
Determining the interaction of Bromfenac Sodium and Insulin Glargine (U-300) Pens and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: bromfenac ophthalmic
Brand name: BromSite, Prolensa, Xibrom, Bromday
Synonyms: Bromfenac (ophthalmic)
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Bromfenac Sodium-Insulin glargine and lixisenatide
- Bromfenac Sodium-Insulin glargine and lixisenatide Subcutaneous
- Bromfenac Sodium-Insulin glargine, recombinant Subcutaneous
- Bromfenac Sodium-Insulin glulisine
- Bromfenac Sodium-Insulin Glulisine (Cartridges and Pens)
- Bromfenac Sodium-Insulin Glulisine (Vials)
- Insulin Glargine (U-300) Pens-Bromhist PDX
- Insulin Glargine (U-300) Pens-Bromhist-PDX Syrup
- Insulin Glargine (U-300) Pens-Bromo Seltzer
- Insulin Glargine (U-300) Pens-Bromocriptine
- Insulin Glargine (U-300) Pens-Bromocriptine (Cycloset)
- Insulin Glargine (U-300) Pens-Bromocriptine (Parlodel)